The global Oral Vaccine Delivery market size is predicted to grow from US$ 2829 million in 2025 to US$ 3901 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031.

Oral vaccines have several attractive features compared with parenteral vaccines, but studies on their use have been limited almost exclusively to protection against mucosally transmitted pathogens.

The oral vaccination market is primarily driven by the advantages it offers in terms of ease of administration, increased patient compliance, and cost-effectiveness compared to traditional injectable vaccines. Oral vaccines provide a non-invasive and painless immunization method, particularly beneficial for pediatric and elderly populations. Additionally, their potential to elicit both systemic and mucosal immunity enhances protection against pathogens that enter the body through mucosal surfaces, such as the respiratory and gastrointestinal tracts, further fueling their adoption. However, the market also faces challenges, including the complex formulation and delivery of oral vaccines, which may affect their stability and efficacy. Developing vaccines that can withstand acidic environments and enzymatic degradation in the gastrointestinal tract poses significant scientific and manufacturing challenges. Moreover, gaining regulatory approvals and ensuring public acceptance of oral vaccines may require extensive clinical data and educational efforts to dispel misconceptions about their safety and efficacy. To overcome these challenges, the industry is focused on research and innovation to improve oral vaccine formulation and delivery technologies. Collaborations between vaccine developers, research institutions, and regulatory authorities are crucial in driving the growth of the oral vaccination market and expanding access to effective and accessible immunization options, particularly in regions with limited healthcare infrastructure.

Infinity Market Research newest research report, the Oral Vaccine Delivery Industry Forecast looks at past sales and reviews total world Oral Vaccine Delivery sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Vaccine Delivery sales for 2025 through 2031. With Oral Vaccine Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Vaccine Delivery industry.

This Insight Report provides a comprehensive analysis of the global Oral Vaccine Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Vaccine Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Oral Vaccine Delivery market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Vaccine Delivery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Vaccine Delivery.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Vaccine Delivery market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Rotavirus Vaccine
    Cholera Vaccine
    Oral Polio Vaccine
    Other

Segmentation by Application:

    Public
    Private

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Merck
    GSK
    Sanofi
    Lanzhou Institute
    Serum Institute
    Valneva
    Shanghai United Cell
    Bibcol
    PaxVax
    Vabiotech
    Tiantan Biological
    EuBiologics
    Panacea Biotec Ltd
    Bio-Med
    Halfkin Bio-Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oral Vaccine Delivery market?
What factors are driving Oral Vaccine Delivery market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Vaccine Delivery market opportunities vary by end market size?
How does Oral Vaccine Delivery break out by Type, by Application?